Cholesterol and beyond-The role of the mevalonate pathway in cancer biology

A Göbel, M Rauner, LC Hofbauer… - Biochimica et Biophysica …, 2020 - Elsevier
Cancer is a multifaceted global disease. Transformation of a normal to a malignant cell takes
several steps, including somatic mutations, epigenetic alterations, metabolic reprogramming …

IL‐17‐producing γδ T cells and innate lymphoid cells

CE Sutton, LA Mielke, KHG Mills - European journal of …, 2012 - Wiley Online Library
The inflammatory cytokine IL‐17 plays a critical role in immunity to infection and is involved
in the inflammatory pathology associated with certain autoimmune diseases, such as …

Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

F Dieli, D Vermijlen, F Fulfaro, N Caccamo… - Cancer research, 2007 - AACR
The increasing evidence that γδ T cells have potent antitumor activity suggests their value in
immunotherapy, particularly in areas of unmet need such as metastatic carcinoma. To this …

Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl …

CT Morita, C Jin, G Sarikonda… - Immunological reviews, 2007 - Wiley Online Library
Human Vγ2Vδ2 T cells play important roles in mediating immunity against microbial
pathogens and have potent anti‐tumor activity. Vγ2Vδ2 T cells recognize the …

[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

Improving the efficiency of Vγ9Vδ2 T-cell immunotherapy in cancer

T Hoeres, M Smetak, D Pretscher… - Frontiers in …, 2018 - frontiersin.org
Increasing immunological knowledge and advances in techniques lay the ground for more
efficient and broader application of immunotherapies. gamma delta (γδ) T-cells possess …

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

S Meraviglia, M Eberl, D Vermijlen… - Clinical & …, 2010 - academic.oup.com
The potent anti-tumour activities of γδ T cells have prompted the development of protocols in
which γδ-agonists are administered to cancer patients. Encouraging results from small …

γδ T cells link innate and adaptive immune responses

W Holtmeier, D Kabelitz - Mechanisms of epithelial defense, 2005 - karger.com
While most T cells use a CD3-associated α/β T cell receptor as antigen recognition structure,
a second population of T cells expresses the alternative γ/δ T cell receptor. γ/δ T cells are a …

Novel aspects of mevalonate pathway inhibitors as antitumor agents

M Thurnher, O Nussbaumer, G Gruenbacher - Clinical Cancer Research, 2012 - AACR
The mevalonate pathway for cholesterol biosynthesis and protein prenylation has been
implicated in various aspects of tumor development and progression. Certain classes of …

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

M Coscia, E Quaglino, M Iezzi, C Curcio… - Journal of cellular …, 2010 - Wiley Online Library
It is unknown whether zoledronic acid (ZA) at clinically relevant doses is active against
tumours not located in bone. Mice transgenic for the activated ErbB‐2 oncogene were …